(Q43552509)

24 November 2017

title

Strategies for induction of clinical tolerance (English)

1 reference

24 November 2017

Monaco AP

1

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

Transplantation Proceedings

24 November 2017

published in

1 reference

24 November 2017

volume

33

1 reference

24 November 2017

issue

1-2

1 reference

24 November 2017

page(s)

51-56

1 reference

Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4(+) T cells, interferon-gamma, and CTLA4.

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2901916-9

7 January 2021

CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2901916-9

7 January 2021

Combined costimulation blockade plus rapamycin but not cyclosporine produces permanent engraftment

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2901916-9

7 January 2021

Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2901916-9

7 January 2021

Quantitative Studies on Tissue Transplantation Immunity. III. Actively Acquired Tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2901916-9

7 January 2021

Mixed allogeneic reconstitution (A+B----A) to induce donor-specific transplantation tolerance. Permanent acceptance of a simultaneous donor skin graft

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2901916-9

7 January 2021

A nonlethal conditioning approach to achieve engraftment of xenogeneic rat bone marrow in mice and to induce donor-specific tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2901916-9

7 January 2021

The effect of injection of donor bone marrow on the frequency of donor-reactive CTL in antilymphocyte serum-treated, grafted mice

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2901916-9

7 January 2021

Superiority of sirolimus (rapamycin) over cyclosporine in augmenting allograft and xenograft survival in mice treated with antilymphocyte serum and donor-specific bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2901916-9

7 January 2021

Long-term Incompatible Kidney Survival in Outbred Higher Primates without Chronic Immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2901916-9

7 January 2021

Promotion of incompatible allograft acceptance in rhesus monkeys given posttransplant antithymocyte globulin and donor bone marrow. II. Effects of adjuvant immunosuppressive drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2901916-9

7 January 2021

Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2901916-9

7 January 2021

Evidence for microchimerism in peripheral blood, bone marrow, and skin following donor bone marrow/kidney-pancreas transplantation at 3 years

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2901916-9

7 January 2021

Establishment of stable multilineage hematopoietic chimerism and donor-specific tolerance without irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2901916-9

7 January 2021

Donor MHC class II antigen is essential for induction of transplantation tolerance by bone marrow cells

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2901916-9

7 January 2021

Microchimerism and rejection in clinical transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2901916-9

7 January 2021

Status of microchimerism in recipients 15 years after living related kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2901916-9

7 January 2021

Tolerance to an HLA-B,DR disparate kidney allograft after bone-marrow transplantation from same donor

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2901916-9

7 January 2021

Immunologic tolerance to renal allografts after bone marrow transplants from the same donors

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2901916-9

7 January 2021

Chimerism and transplantation tolerance: cause and effect

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2901916-9

7 January 2021

Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2901916-9

7 January 2021

Thymic dependence of loss of tolerance in mixed allogeneic bone marrow chimeras after depletion of donor antigen. Peripheral mechanisms do not contribute to maintenance of tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2901916-9

7 January 2021

Use of pharmacologic immunosuppression to augment the specific unresponsiveness (tolerance) to skin allografts induced by donor-specific bone marrow in antilymphocyte serum-treated mice: the unique effect of sirolimus.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2901916-9

7 January 2021

p70s6k/p85s6k: mechanism of activation, effects of rapamycin and role in mitogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2901916-9

7 January 2021

Rapamycin inhibits p34cdc2 expression and arrests T lymphocyte proliferation at the G1/S transition.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2901916-9

7 January 2021

Differential effects of the immunosuppressive macrolides FK-506 and rapamycin on activation-induced T-cell apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2901916-9

7 January 2021

T-cell growth factors in allograft rejection and tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2901916-9

7 January 2021

Additional monoclonal antibody (mAB) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2901916-9

7 January 2021

Durable donor-specific T and B cell tolerance in rhesus macaques induced with peritransplantation anti-CD3 immunotoxin and deoxyspergualin: absence of chronic allograft nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2901916-9

7 January 2021

Molecular mechanisms of immunosuppression by cyclosporine, FK506, and rapamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2901916-9

7 January 2021

10.1016/S0041-1345(01)01916-9

Identifiers

DOI

1 reference

24 November 2017

1 reference